74 related articles for article (PubMed ID: 2502049)
1. [Use of a technic of bioluminescence for determining estrogens and LH during static and dynamic study of the ovary].
Cristol P; Alameddine S; Terouanne B; Nicolas JC; Arnal F; Hedon B; Crastes de Paulet A
Ann Biol Clin (Paris); 1989; 47(4):167-80. PubMed ID: 2502049
[TBL] [Abstract][Full Text] [Related]
2. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
3. [Steroids and the prediction of ovulation].
Audebert AJ; Emperaire JC; Ruffie A
Contracept Fertil Sex (Paris); 1984 Feb; 12(2):411-9. PubMed ID: 12265829
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
5. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
[TBL] [Abstract][Full Text] [Related]
6. Comparison between IVF and GIFT using the GnRH agonist protocol.
Cittadini E; Palermo R; Agrifoglio V
Acta Eur Fertil; 1988; 19(1):41-4. PubMed ID: 3137763
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the LH profile in relation to ovarian stimulation regimes and embryo transfer rates in an in vitro fertilisation programme.
Umapathysivam K; Jones WR; Meffin E
Clin Reprod Fertil; 1986 Jun; 4(3):227-32. PubMed ID: 3091237
[TBL] [Abstract][Full Text] [Related]
8. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction.
Andersen CY; Humaidan P; Ejdrup HB; Bungum L; Grøndahl ML; Westergaard LG
Hum Reprod; 2006 Aug; 21(8):2126-30. PubMed ID: 16682403
[TBL] [Abstract][Full Text] [Related]
9. Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. II. Comparison of hMG and recombinant FSH.
Duijkers IJ; Willemsen WN; Hollanders HM; Hamilton CJ; Thomas CM; Vemer HM
Int J Fertil Womens Med; 1997; 42(6):431-5. PubMed ID: 9459089
[TBL] [Abstract][Full Text] [Related]
10. Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study.
Ferrari B; Barusi L; Coppola F
J Reprod Med; 2002 Feb; 47(2):137-43. PubMed ID: 11883353
[TBL] [Abstract][Full Text] [Related]
11. [The plasma and urinary hormone profiles during treatment with human gonadotrophins (author's transl)].
Salat-Baroux J; Scemama-Kestenberg H
J Gynecol Obstet Biol Reprod (Paris); 1978; 7(7):1269-90. PubMed ID: 744868
[TBL] [Abstract][Full Text] [Related]
12. Risk of repeated spontaneous luteinizing hormone surges in ovarian stimulation for in vitro fertilization.
Nisker JA; Bloch CL; Tummon IS; Daniel SA; Yuzpe AA
J Reprod Med; 1993 Jun; 38(6):413-6. PubMed ID: 8331617
[TBL] [Abstract][Full Text] [Related]
13. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. 1. FSH and LH profiles].
Sudik R; Fliess FR; Kunkel S
Zentralbl Gynakol; 1987; 109(24):1478-92. PubMed ID: 3126616
[TBL] [Abstract][Full Text] [Related]
14. Induction of follicular growth, ovulation and luteinization in the human ovary.
Edwards RG; Steptoe PC
J Reprod Fertil Suppl; 1975 Apr; (22):121-63. PubMed ID: 1058970
[TBL] [Abstract][Full Text] [Related]
15. [Ovarian stimulation: a new approach based on recent physiological and clinical data. Future perspectives].
Lunenfeld B
Contracept Fertil Sex; 1993 Apr; 21(4 Suppl):1-7. PubMed ID: 7951638
[TBL] [Abstract][Full Text] [Related]
16. [A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].
Ye H; Huang G; Pei L
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):222-5. PubMed ID: 11783366
[TBL] [Abstract][Full Text] [Related]
17. The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization.
Acosta AA; Bernardus RE; Jones GE; Garcia J; Rosenwaks Z; Simonetti S; Veeck LL; Jones D
Acta Eur Fertil; 1985; 16(2):81-99. PubMed ID: 3929523
[TBL] [Abstract][Full Text] [Related]
18. Long GnRH-agonist protocol in an IVF program. Is it appropriate for women with normal FSH levels and high FSH/LH ratios?
Yang JH; Wu MY; Chao KH; Chen SU; Ho HN; Yang YS
J Reprod Med; 1997 Oct; 42(10):663-8. PubMed ID: 9350023
[TBL] [Abstract][Full Text] [Related]
19. [Enzymatic determination of urinary estrogens. A 5-year experience in a hospital milieu].
Cristol P; Hedon B; Chabab A; Bringer J; Diafouka F; Mares P; Crastes de Paulet A; Viala JL
Ann Biol Clin (Paris); 1985; 43(6):841-50. PubMed ID: 3832976
[TBL] [Abstract][Full Text] [Related]
20. The effects of GnRH analogue (buserelin) or hCG (Chorulon) on Day 12 of pregnancy on ovarian function, plasma hormone concentrations, conceptus growth and placentation in ewes and ewe lambs.
Khan TH; Beck NF; Khalid M
Anim Reprod Sci; 2007 Dec; 102(3-4):247-57. PubMed ID: 17174489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
